SCHEMBL23723112

SCHEMBL23723112

CCCCCCCC(Cl)CC(=O)OC

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.49
MEN1 O00255 1/20 0.45
HPGD P15428 1/20 0.45
RECQL P46063 1/20 0.45
KMT2A Q03164 1/20 0.45
HSD17B10 Q99714 1/20 0.45
FAAH O00519 4/20 0.45
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
BIRC2 Q13490 1/20 0.44
GPR84 Q9NQS5 7/20 0.43
POLB P06746 1/20 0.42
POLA1 P09884 1/20 0.42
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
FFAR1 O14842 1/20 0.41
MAPT P10636 1/20 0.40
EPHX1 P07099 1/20 0.40
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22719982 0.85 GPR84 (0.43) ZDHHC7FAAHLMNAGPR84CNR1
SCHEMBL28623845 0.84 ZDHHC7 (0.43) ZDHHC7FAAHGPR84FFAR1MAPT
SCHEMBL28637271 0.84 ZDHHC7 (0.43) ZDHHC7FAAHGPR84FFAR1MAPT
SCHEMBL11479392 0.84 LMNA (0.50) ZDHHC7LMNAPOLBPOLA1MAPT
SCHEMBL28630516 0.81 ZDHHC7 (0.41) ZDHHC7FAAHGPR84FFAR1MAPT
SCHEMBL562984 0.81 TSHR (0.45) ZDHHC7MEN1HPGDRECQLKMT2A
SCHEMBL5074118 0.81 ZDHHC7 (0.52) ZDHHC7MEN1HPGDRECQLKMT2A
SCHEMBL5075427 0.81 ZDHHC7 (0.52) ZDHHC7MEN1HPGDRECQLKMT2A
SCHEMBL22590010 0.81 ZDHHC7 (0.52) ZDHHC7MEN1HPGDRECQLKMT2A
SCHEMBL5079165 0.81 ZDHHC7 (0.52) ZDHHC7MEN1HPGDRECQLKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210247400-A1 ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF Technische Universität München (DE) 2021-08-12 US disclosed
US-20210247400-A1 ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF Technische Universität München (DE) 2021-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210247400-A1 ACTIVATION OF PATTERN-TRIGGERED IMMUNITY IN PLANTS BY LIPOOLIGOSACCHARID-SPECIFIC REDUCED ELICITATION (LORE) AND VARIANTS THEREOF PGLS, LIPE, LYPLA2 ZDHHC7 438/4885MEN1 4383/4885HPGD 2262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.